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Abstract
Introduction. Breast cancer is the second most common malignancy in women. The Decision Quality Instrument
(DQI) measures the extent to which patients are informed and involved in breast surgery decisions and receive treatment that aligns with their preferences. There are limited data on the performance of the DQI in women of lower
socioeconomic status (SES). Our aims were to 1) examine (and if necessary adapt) the readability, usability, and
acceptability of the DQI and 2) explore whether it captures factors important to breast cancer surgery decisions
among women of lower SES (relevance). Methods. We conducted semistructured cognitive interviews with women of
lower SES (based on insurance status, income, and education) who had completed early-stage breast cancer treatments at three cancer centers. We used a two-step thematic analysis with dual independent coding. The study team
(including Patient Partners and a Community Advisory Board) reviewed and refined suggested changes. The revised
DQI was presented in two focus groups of breast cancer survivors. Results. We conducted 39 interviews. Participants
found most parts of the DQI to be helpful and easy to understand. We made the following suggested changes: 1)
added a glossary of key terms, 2) added two answer choices and an open text question in the goals and concerns subscale, 3) reworded the treatment intention question, and 4) revised the knowledge subscale instructions since several
women disliked the wording and were unsure of what was expected. Discussion. The readability, usability, acceptability, and relevance of a measure that was primarily developed and validated in women of higher SES required adaptation for optimal use by women of lower SES. Further research will test these adaptations in lower SES populations.
Keywords
acceptability, breast cancer surgery, decision making, decision quality, lower socioeconomic status, readability
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Nearly one in eight women will be diagnosed with breast
cancer in their lifetime.1,2 Despite significant overall
improvements in breast cancer survival, disparities in
care experiences and outcomes persist.3,4 Women of
lower socioeconomic status (SES) diagnosed with earlystage breast cancer (stages I to IIIA) report poorer
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communication with their health care providers, lower
knowledge of breast cancer surgery, and higher receipt
of mastectomy rather than breast conserving surgery
(BCS), compared with women of higher SES.3–11 They
are also likely to experience worse health outcomes and
increased mortality compared with women of higher
SES.3,12,13
While BCS is recommended to treat early-stage breast
cancer, research demonstrates equivalent survival
between mastectomy and BCS.14–19 Both options are
offered routinely, but patients value the harms and benefits of each treatment option differently.3,20 Since clinical
equipoise exists, this breast cancer treatment decision is
considered preference-sensitive, warranting patient involvement in decision making.21,22 According to the
Institute of Medicine, patient participation in decision
making should be promoted to improve the quality of
health care, particularly for cancer care.23 All women
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diagnosed with early-stage breast cancer should be supported in making high-quality breast cancer surgery decisions that are informed by adequate knowledge of breast
cancer treatment options, and aligned with their values
and preferences, regardless of SES.24,25 However, across
all socioeconomic strata, only 44% to 51% of women
with early-stage breast cancer achieve the degree of participation in decision making they desire, and women
commonly report poor knowledge of breast cancer surgery.5,6,26–29 Women of lower SES with early-stage breast
cancer are more likely to have lower knowledge of breast
cancer surgery, to play a passive role in decision making,
to have higher decision regret, and to have lower satisfaction with treatment decision making compared with
women of higher SES.4,5,8,9,11
In the context of preference-sensitive decisions such as
early-stage breast cancer surgery, the quality of the treatment decision cannot be determined by clinical factors
only.30,31 In 2006, an international consensus process was
used to define decision quality as the extent to which 1)
patients are informed and 2) choose treatments that match
what is most important to them.32 This definition guided
the development of the Decision Quality Instrument
(DQI) for early-stage breast cancer.33 The DQI measures
the extent to which patients are informed about and
involved in medical decision making and receive surgery
that is aligned with their goals and preferences.34 The DQI
includes three sections and produces three scores: 1)
decision-specific goals and concerns to examine the extent
to which patients received treatment that is aligned with
their goals (goals and concerns subscale), 2) decisionspecific knowledge to assess patient understanding of the
options and outcomes (knowledge subscale), and 3) the
extent to which patients are meaningfully involved in the
decision-making process with their health care provider
(decision process subscale).34
The DQI was primarily developed and evaluated in
women of higher SES. Of the 35 breast cancer survivors
who were involved in developing the measure, 77% had
received some college education or a college degree, and
97% were Caucasian.33 In the validation study (n = 440
patients), 87.5% had received some college education or
a college degree, 83% were Caucasian, and 86.6%
reported an annual income of more than $30,000.34 In
2010, a cross-sectional survey featuring the DQI was
mailed to Latina breast cancer patients to examine the
quality of surgical decision making in this group.35 The
sample included a sizeable proportion of women of lower
SES. Of 97 Latina breast cancer survivors, 58.8% did
not receive a college education and 50.5% reported an
annual income of $30,000 or less. The study response
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rate was low (42%); this was attributed to staff turnover
and variable adherence to the protocol. Furthermore,
Sepucha and colleagues suggested that the low response
rate may also be due to a lack of acceptability of the survey among Latina respondents, about half of whom
seemed to report lower income and lower educational
attainment than survivors who had previously completed
the DQI.33,34 However, there was no comprehensive
assessment of the readability, usability, and acceptability
of the DQI in English-speaking women of lower SES of
varying race and ethnicity.36 It is, therefore, unclear
whether the DQI is readable, usable, and acceptable to
women of lower SES. It is also uncertain whether the
current validated version of the DQI captures the factors
(including potential barriers) that are important to
women of lower SES when deciding about early-stage
breast cancer treatments. There is limited evidence
regarding the values and preferences of women of lower
SES considering surgical treatments for early-stage
breast cancer.37
Our aims were to 1) examine (and if necessary adapt)
the readability, usability and acceptability of the DQI in
women of lower SES and 2) explore whether the goals
and concerns subscale captures the factors that are
important to them when deciding about early-stage
breast cancer treatments. This study is the first to specifically explore the readability, usability, acceptability, and
relevance of the DQI to people of lower SES.

Methods
We conducted a cross-sectional qualitative study of the
readability, usability, acceptability, and relevance of the
DQI among women of lower SES diagnosed with earlystage breast cancer who had completed treatments in the
past 3 years. We used semi-structured cognitive interviews integrating verbal probing techniques. This study
was designed and conducted according to the consolidated criteria for reporting qualitative research
(COREQ) (see Supplemental File 1 for checklist).38

Study Population
We used purposive sampling and targeted women of
lower SES who had completed treatments for early-stage
breast cancer in the past 3 years at DartmouthHitchcock Medical Center (DHMC) in Lebanon, New
Hampshire; Montefiore Medical Center in the Bronx,
New York; and Joanne Knight Breast Health Center in
St. Louis, Missouri.

We used the following inclusion and exclusion criteria. Inclusion criteria were the following: 1) assigned
female at birth; 2) between 18 and 74 years of age; 3) low
SES using insurance status (uninsured or on Medicaid or
Medicare without supplemental insurance), educational
attainment, annual household income, and information
provided by the social worker and care team; 4) completed treatments for early-stage breast cancer (stages IIIIA) within the past 3 years (so that they could reflect
on their full care path and not have the burden of currently undergoing treatment); and 5) had at least a basic
command of spoken English. Exclusion criteria were the
following: 1) transgender men and women, 2) women
who had undergone prophylactic mastectomy, 3) women
.74 years of age, 4) women with visual impairment, and
5) women with inflammatory breast carcinoma.
We intended to recruit up to 15 eligible participants at
each of our three sites or recruit participants until data
saturation was reached and no new themes emerged.39

Data Collection
Subject Recruitment. To screen for eligible participants,
research assistants at Montefiore Medical Center and
Joanne Knight Breast Health Center reviewed medical
records for eligibility using the aforementioned inclusion
and exclusion criteria. Social workers and relevant care
team members were consulted as necessary to confirm
participants’ eligibility. At DHMC, the oncology social
worker of the Comprehensive Breast Program performed
the initial screening, spoke to patients, and transferred
the contact information of eligible and interested patients
to the research assistant using a password-protected file.
At each site, research assistants contacted eligible patients
by sending a study information sheet and an introduction
letter in the mail. The information sheet (Supplemental
File 2) first described the purpose of the interview and
the characteristics of the participants. The information
sheet integrated pictures and used plain language (readability: seventh-grade level). It was developed iteratively
to improve readability and understanding, with input
from our patient partners, several of whom are breast
cancer survivors. A series of frequently asked questions
appeared on page two of the information sheet. The contact information of the research coordinator, principal
investigator, and institutional review board office was
provided on the last page (Supplemental File 2).
Cognitive Interviews. The research assistants who contacted eligible patients (JS: female research assistant;
NM: female research assistant; TDG: male research
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assistant) were those who conducted the interviews. All
research assistants had prior experience conducting qualitative interviews with patients. However, not all
research assistants had conducted cognitive interviews in
the past. Prior to starting data collection, the study principal investigator (M-AD) and research project coordinator (RWY) trained all research assistants in conducting
cognitive interviews following verbal-probing techniques.40–43 After reviewing each DQI question together,
the interviewer asked for other specific information
related to the question or to the answer given. The principal investigator has experience using these techniques.44–
47
In order to ensure quality control and standardization
of the data collection methods across all sites, the principal investigator and research project coordinator read
the first and fifth interview transcripts received from each
site and provided timely feedback on each interview, so
necessary changes could be implemented for subsequent
interviews.
After screening for eligibility, the research assistants
followed-up with a telephone call to discuss the study
and schedule a time to conduct the interview via phone
or in person. No relationship with the participants had
been established prior to study recruitment. When possible, the research assistants met the patients when they
came to the clinic for a follow-up appointment. If the
patient preferred to schedule an interview on the phone,
the research assistant mailed the materials and called the
patients at the scheduled time. All interviews were audio
recorded. Before the interview began, the research assistants introduced themselves, gave participants an opportunity to review the study information sheet, to ask any
questions, and obtained verbal consent.
First, research assistants asked participants to complete the DQI as if they had recently received a new
breast cancer diagnosis and needed surgical treatment.
Research assistants left the room or waited silently on
the phone for a few minutes to give participants an
opportunity to read the DQI and make any notes.
Second, after participants had finished reading the DQI,
the research assistants began semistructured interviews
following a cognitive-interviewing script that focused on
readability, usability, and acceptability of all instructions
and questions (see Supplemental File 3). Interviewers
gathered general impression about the worksheet, inviting any comments, including negative ones, on the
instructions appearing on the first page. Participants
were asked to explain, using their own words, what the
instructions and items meant. The research assistant subsequently covered each subscale to focus on the instructions and items, one by one. For the goals and concerns
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subscale, interviewers asked additional questions about
factors that mattered most to participants when deciding
between mastectomy and lumpectomy (relevance).
After the interview ended, participants were asked to
complete a demographics survey consisting of 15 questions: 1) time since breast cancer diagnosis, 2) time
between diagnosis and surgery, 3) health insurance at the
time of diagnosis, 4) health insurance coverage of breast
cancer treatment, 5) current insurance, 6) country of
birth, 7) English proficiency, 8) gender, 9) race, 10) ethnicity, 11) age, 12) highest educational attainment, 13)
employment status, 14) household income, and 15)
Chew’s Single Item Literacy Screener.48 Participants
were given the option of completing the questionnaire on
paper, verbally over the phone, or electronically (i.e., via
tablet). After completing the questionnaire, all participants received a $15 gift card. No field notes were made.
No repeat interviews were carried out.

Data Analysis
A HIPAA-compliant company transcribed the interview
recordings. We used a two-step thematic analysis,
assisted by the computer software ATLAS-ti.49–51 Three
reviewers coded the transcripts independently, one
reviewer coded all transcripts (JS), and two reviewers
split the full set due to staffing changes (AW and PS).
First, the reviewers coded the transcripts to identify DQI
items and instructions that required adaptation, as well
as factors that matter to women when deciding about
breast cancer surgery. The coders convened after independently coding five transcripts to review and agree on
the themes and codes that had emerged in order to create
a codebook, which was used to code all remaining interview transcripts. In a second and more detailed analysis,
we coded the interview transcripts according to all the
themes discussed in the interviews, including spontaneously emerging themes. The raters discussed discrepancies with the principal investigator of the study
(M-AD) until consensus was reached. We developed the
emerging themes into specific set of changes for the
DQI. We typically considered themes that appeared at
least five unique times in the interviews for the revised
DQI (DQI-R). We subsequently discussed the list of
codes and preliminary findings with Dr. Sepucha (measure developer of the DQI), our patient partners (LW,
EC, SJ, AB), our Community Advisory Board, and the
broader study team. After consensus on appropriate
changes from these study groups, we developed and
reviewed the DQI-R. We subsequently presented it in
two focus groups of breast cancer survivors of varying
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SES. Each focus group went through and provided feedback (i.e., acceptable or recommended changes) for each
section of the DQI-R.

Results
Participants
Over 3 months, we identified 102 potentially eligible
patients and confirmed eligibility for 75. We contacted
these 75 women and interviewed 39: 12 at DHMC, 14 at
Montefiore Medical Center, and 13 at Washington
University in St. Louis. The remaining 36 either did not
respond to the researcher or did not agree to take part.
We reached thematic saturation where no new themes
were emerging after conducting 38 interviews and stopped
data collection (after interview 39). All but one participant completed the demographic survey. Not all questions were answered by all participants (see Table 1). On
average, participants had been diagnosed with early-stage
breast cancer 2.4 years prior to being interviewed.
Participants’ mean age was 52.6. Half of the sample were
Caucasian. The majority of participants (22/39) did not
have a college degree, were in receipt of Medicaid or uninsured at the time of diagnosis (31/39), and reported a
household income of $35,000 or less (24/39). Less than
half were employed part-time or full-time time. Interviews
lasted between 9 and 93 minutes, with an average of 42.60
minutes. Most women (24/39) reported adequate health
literacy (see Table 1 for more details).

Thematic Analysis
The independent coders agreed on a codebook of 25 codes.
Two major themes emerged from the interviews, in alignment with the interview guide: 1) what matters most to
women when choosing early breast cancer treatment and
2) readability, usability, and acceptability of the DQI
(including suggestions for improvement) (see Table 2).
Theme 1: What Matters Most When Choosing Breast
Cancer Surgical Treatments. When asked about what
mattered to them in making a surgery decision, half of
the sample (n = 20) reported not being given an explicit
choice between mastectomy and BCS to treat their earlystage breast cancer.
They didn’t give me much options and I just told them do
whatever they have to do because I just wanted to live.
(Transcript 16, age 48)

When discussing what mattered most in choosing
their surgical treatment, the most prevalent subtheme

was the importance of survival, recurrence, and cure
(n = 31). Women mentioned ‘‘[being] cancer-free,’’ ‘‘the
chances of it spreading,’’ and ‘‘wanting to live.’’ Most
women were able to make a distinction between survival
and recurrence, and seemed to understand that their surgery choice would not affect their overall survival.
However, a minority of women talked about choosing
the type of surgery that would maximize survival, thus
pointing to a gap in knowledge.
You know, what’s important to me is basically overall survival. You know, yes my breast is important but, you know,
given the choice between one or the other, I’m going to
choose survival. (Transcript 6, age 58)

Nineteen participants expressed the importance or influence of other people in making a surgery decision.
My husband, my spouse, had influence in the decision making ( . . . ) you know, listening to the pros and the cons for
me being, you know, another opinion. I would like to have
another voice there, so I found that to be very helpful.
(Transcript 10, age 37)

Effects or side effects of surgery, including recovery time
and ability to maintain pre-cancer lifestyle, were also
important (n = 15).
I’m very active, I wouldn’t want to have a procedure that
would ultimately render me not able to do things like swimming or kayaking, you know things like that. (Transcript
36, age 60)
Recovery time. Because of my job, because of work.
Responsibility at work. (Transcript 39, age 44)
I’m a very independent person and I didn’t want that [weak]
feeling. (Transcript 35, age 63)

Patients felt that the trust in and relationship with their
doctor (n = 15) played a significant role in their
decision-making process.
I had to fully trust my surgeon. (Transcript 42, age 42)

For some of those patients, boundless trust in their doctors occasionally meant following the doctor’s recommendation, thus overriding their own decisional power.
So, I decided, you know, whatever the doctors thought was
the right procedure, you know, I just told them, go ahead
you know what you’re doing, I trust you, you know. It is

6

MDM Policy & Practice 00(0)

Table 1 Demographic Characteristics (n = 37a)
Characteristics and Categories
Age, mean (range)
How long ago, mean (range), were you diagnosed with breast cancer?
Time between diagnosis and surgery, mean (range)
Race/ethnicity
American Indian or Alaska Native
Asian
Black or African American
Hispanic
White or Caucasian
In what country were you born?
USA
US Virgin Island
Dominican Republic
Jamaica
Puerto Rico
Roughly how old were you when you learned English?
0–5 years old
16–20 years old
Education
Professional degree
4-year degree
2-year degree
Some college, no degree
High school diploma or equivalent
No high school diploma
Not reported
Health insuranceb at time of treatment
Medicaid or other state-sponsored
Medicare
Private Insurance
Uninsured
Health insurance covered all or part of breast cancer treatment
Yes
No
Not reported
Current health insurance
Medicaid or other state-sponsored
Medicare
Private insurance
Working status at time of interview
Part-time work (15–34 hours per week)
Full-time work
On temporary leave
Full-time student
Not working at the moment
Retired
Other
Annual household income, US$
Less than $20,000
$20,000 to $34,999
$35,000 to $49,999
$50,000 to $74,999
Not reported
How confident are you in filling out medical forms by yourself?
Extremely
Quite a bit
Somewhat
A little bit
Not at all
Not reported
a

n
52.6 (31–70) years
2.4 (0.25–5) years
10 (1–54) weeks
1
1
13
3
20
34
1
1
1
1
37
1
4
4
8
12
5
4
1
22
8
7
1
31
2
5
23
8
7
4
10
1
1
7
7
5
19
5
7
4
3
24
6
1
1
1
5

One participant did not complete the demographic survey. Some participants did not answer one or several questions within the demographic survey.
Some participants selected multiple insurance categories.

b
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Table 2 Themes and Subthemes Identified in Interviews
Themes
1. What matters most to women

2. Readability, usability, and acceptability of the
Decision Quality Instrument

good that I found a brave surgeon, a person who I trust,
and who made me feel confident. (Transcript 38, age 48)
Talk with your doctor and hear their suggestions and then
you decide and if you’re not comfortable, get a second opinion. (Transcript 35, age 63)

For others (n = 14), ‘‘avoid having radiation’’ was important due to fears regarding pain, scar tissues, and side
effects. Participants also mentioned that their personal
characteristics and medical history (n = 13), such as ‘‘what
stage I was in’’ or ‘‘the grade of cancer’’ mattered to them
in making a surgical treatment decision. Others mentioned
concerns for family and others (n = 12).
The first thing I thought of was when I was diagnosed, the
thing that popped in my head is, I have children. And my
children need to be raised by a mom, and you know, a mom
and a dad. And so, my thought was that what mattered most
to me was my family. (Transcript 39, age 44)

Waiting time between diagnosis and surgery was important to some participants (n = 10).
I preferred to have [the surgery] done immediately. The
faster you attack something, the better for you. The better
you know outcome for you to live. (Transcript 11, age 47)
I think what gets most cancer patients down, no matter what
type of cancer it is, probably more so the breast cancer, is
that it’s the hurry up and wait. (Transcript 41, age 70)

In this study population, women were more likely to
report that keeping their breast was not essential (n =
12) compared with those who felt it was important to
their treatment decision (n = 10). Some stated that
cost was not a factor in making a treatment decision
(n = 18), although a sizable proportion took cost into
account (n = 11). Interviewees mostly referred to
the monetary cost of treatment (health care bills and

Subthemes










Survival, elimination of cancer, recurrence
Avoiding radiation
Relationship with the doctor
Ability to maintain independence and lifestyle
Support system
Concern for family
Cost
Good readability, usability, and acceptability overall
Suggested modifications to improve readability

out-of-pocket expenses) but did not specify whether
cost influenced them to choose one surgery over the
other. Of the 11 patients who mentioned the importance of cost in their decision-making process, 9 were
receiving Medicaid or other state-sponsored insurance,
or Medicare without supplemental insurance at the
time of diagnosis.
While the codes and their respective occurrence provided
important insights into the factors that mattered most to
women of lower SES when making early-stage breast cancer treatment decisions, not all codes were relevant to the
adaptation of the concerns and goals subscale of the DQI.
In order to explore whether the DQI can determine whether
the treatment decision is aligned with patients’ goals and
concerns, we focused on informed preferences and aimed to
integrate factors that would influence a patient’s decision
toward either surgery option. For instance, a majority of
participants mentioned the importance of survival and eliminating cancer. However, this prominent concern for any
woman diagnosed with early-stage breast cancer would not
be a driver in their surgical decision as both mastectomy
and BCS have similar outcomes in terms of survival. Cost
was considered an important part of the decision-making
process for 11 out of 39 patients.
Theme 2: Readability, Usability, and Acceptability of the
Original DQI. Almost all participants (n = 37) considered that the overall DQI instructions were clear and easy
to understand.
I think it’s pretty self-explanatory. (Transcript 8, age 48)
[Directions are] very understandable. (Transcript 32, age 53)
They are all straightforward, easy. (Transcript 1, age 57)

Nearly half of participants (n = 19) reported positive
reactions to the DQI. They found it to be ‘‘very helpful’’
and ‘‘important.’’
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It would have helped me out a lot in coming up with my
decision. (Transcript 33, age 43)

It didn’t really say a whole bunch about chemo on this.
(Transcript 35, age 63)

I thought it was pretty thorough in asking the questions and
the questions were good questions on it. (Transcript 8, age 48)

This seems like this could be at this point, some kind of a,
maybe an open-ended question ( . . . ) a little essay question.
(Transcript 4, age 52)

I think this helps you determine whether or not you know,
how much do you yourself know, and how much this doctor
know. (Transcript 41, age 70)

Fewer participants (n = 10) expressed their concern
about the timing of administration of the measure:

Several women found the DQI difficult to understand
because of the medical terms such as mastectomy or
radiation that may be difficult to process when hearing
those terms for the first time, during the initial diagnosis.

That’s the big issue at the beginning. It is—it is—this is
overwhelming. (Transcript 20, age 44)

I didn’t know what questions to ask because I didn’t know
technically what breast cancer even was, other than the
word. (Transcript 18, age 43)

For someone who is just finding out like for me, no. I
wouldn’t have a peace of mind because like in that moment,
it’s like, I have to sit there and think, oh my God, like I’m
going to be actually without breast for the remaining of my,
you know, life like. . . . Maybe come to me when everything
is done, you know. (Transcript 10, age 37)

You have a lot of questions asking me the same thing so I
have to exactly, in my head, I have to exactly understand
which word means what. Do you understand what I’m saying? So, I don’t know the difference of this. I don’t know
that. (Transcript 11, age 47)

Sixteen participants felt that certain phrases were confusing or suggested revisions to improve comprehension.
It’s saying early breast cancer. I want to know what’s considered early. (Transcript 19, age 64)
Some of the questions are worded a little strange. . . . I don’t
know how to answer that because I’m not trying to avoid a
treatment, you want to avoid the disease you know.
(Transcript 27, age 47)

Nine participants suggested revising the instructions.
Yeah, or maybe saying you know yeah, we’re asking you
( . . . ) about the average breast cancer case. I think that
make it clearer that that’s what you’re asking I guess.
(Transcript 4, age 52)
Maybe I would say these are questions about some facts
that are important to patients to know all right and maybe
just please do your best to answer each question to the best
of your knowledge or something what works to that effect.
(Transcript 15, age 63)

Many participants did not understand that the knowledge questions included facts that are accurate for an
average early-stage breast cancer patient (n = 21).
Participants also felt that the knowledge subscale was
difficult to answer or felt like a test (n = 17). Several
suggested additional items that may be beneficial to
include, such as questions about chemotherapy, reconstruction, or an open text response (n = 10).

Changes and Adaptations to the DQI in
Response to Participant Feedback
In response to the analyses, several modifications were
made to revise the DQI for this population. First, in
response to feedback about the medical terminology, we
added a short glossary to define key terms used on the
first page: early-stage breast cancer, lymph nodes, lumpectomy, breast reconstruction, mastectomy, and radiation therapy (see Supplemental File 4).
Second, aligned with Theme 1, we made changes to
the goals and concerns subscale. We added two questions to the section: ‘‘How important is it to you to . .
.’’ First, ‘‘Have reconstruction to make a breast shape?’’
and, second, ‘‘Avoid more surgery?’’ To improve
understanding, we revised the question, ‘‘Which treatment do you want to do to treat your early-stage breast
cancer?’’ to ‘‘At the moment, what option are you leaning toward to treat your early-stage breast cancer?’’ In
order to capture any other factors that patients may
consider or want to share, we also added an openended question, ‘‘Is there anything else that is important to you that we have missed?’’
Third, to address the concern that the knowledge subscale felt like a quiz, we revised the instructions to read,
‘‘We would like to check if we have done a good job at giving you information about breast cancer. Please answer the
following questions using what you have read and heard
from your care team so far.’’ No changes were made in the
response options or in the last subscale, decision process.
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The study team, including Dr. Sepucha, our Community
Advisory Board, and patient partners who have completed
all breast cancer treatments, reviewed the final version of
the DQI and found all changes acceptable (see DQI-R in
Supplemental File 4). The focus groups, conducted in
Lebanon, New Hampshire, and St. Louis, Missouri, were
attended by 7 and 15 women, respectively. We received no
suggestions for amendments to the DQI-R from either
focus group. All attendees found the DQI-R to be readable,
usable, and acceptable.

Discussion
This study was the first to interview people of lower SES
to determine the readability, usability, acceptability, and
relevance of the DQI. Overall, participants considered
most parts of the DQI to be helpful and easy to understand. However, several aspects of the measure proved
challenging or incomplete for a sizeable proportion of our
lower SES sample, justifying revisions to two out of three
DQI subscales. After reviewing all comments and consulting Dr. Sepucha, author of the DQI, modifications to
improve the readability, usability, acceptability, and broad
relevance of the DQI were made. In the goals and concerns subscale, we added two questions using the ‘‘Not at
all important’’ to ‘‘Extremely Important’’ scale and an
open-ended question to capture factors that matter most
to women and may not be captured elsewhere. The last
question was revised to assess their treatment intention
more explicitly. The instructions in the knowledge subscale
were revised to clarify the reference point and to reassure
patients that the purpose was to assess the care team’s
effectiveness in communicating information. A glossary
was added. The DQI-R was deemed readable, usable, and
acceptable; this was confirmed by the patient partners and
by 22 breast cancer survivors who attended two separate
focus groups and requested no further changes.
The strengths of this study lie in the diversity of the
study participants, careful training, and ongoing feedback provided to all research assistants conducting the
interviews. We interviewed women in three geographically diverse areas of the country (Lebanon, New
Hampshire; Bronx, New York; and St. Louis, Missouri)
in order to improve the generalizability of our findings.
Former breast cancer patients of various educational
backgrounds, income, age, and race/ethnicity provided
comments and suggestions for improvement, which were
reviewed by M-AD, JS, RWY and Dr. Sepucha, to make
this instrument more appropriate for women of lower
SES. The fact that half of the sample reported not being
given a choice between lumpectomy and mastectomy
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may be considered a limitation of the study. It also
points to the need for improved decision support in this
population. Furthermore, a small proportion of our
sample reported having private health insurance (n = 7)
although we actively targeted women of lower SES who
were uninsured or on Medicaid or Medicare without
supplemental insurance. During the screening process, it
was not always possible to know the patient’s insurance
status ahead of time. So, all other information available
and the social workers’ and other care team members’
assessments were used to determine the estimated SES of
the potential participant. Another limitation is the relatively high health literacy level reported by 24 participants in our sample (61.5%), as measured using Chew’s
Single Item Literacy Screener. Social desirability bias
could have affected the responses participants provided
on the health literacy scale. This bias may have led some
participants to respond to those questions based on
social expectations. Furthermore, only English speakers
were invited to take part in the study.
A prior study has demonstrated feasibility and reliability of a previous version of the DQI in a sample that was
mostly Caucasian with high education and high annual
income.34 In this highly educated sample, three goals were
significantly associated with surgery choice: desire to keep
breast, remove breast for peace of mind, and avoid radiation. In our sample, desire to keep breast was not considered essential. However, fear of recurrence and survival
(remove breast for peace of mind) and avoiding radiation
were important factors. Fear of recurrence has previously
been reported as a determining factor in early-stage breast
cancer surgery decisions among low-income women.8
Other factors that were not captured in Sepucha’s
higher SES sample34 emerged in our lower SES sample
and led to the addition of two goals and one open-ended
question: have reconstruction to make a breast shape,
and avoid more surgery. The goal of avoiding more surgery could be related to financial considerations, although
there is limited evidence regarding the impact of limited
financial resources on breast cancer surgery decision making.8,52 The open-ended question was created to capture
other factors that were important to women of lower SES
but that may not always be a driver in their surgical decision (such as cost, or trust in their doctor).
Trust in their doctor and how much control the doctor
exerted over the decision-making process has been shown
to be an important factor in breast cancer surgery decision making among women of lower income and lower
SES. McVea and colleagues8 interviewed 25 women of
lower income diagnosed with early-stage breast cancer
about their experiences deciding between surgical
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treatment options. The physician’s style, and specifically
the degree to which she/he permitted or encouraged
patient participation in decision making, strongly influenced the treatment choice. In McVea’s sample, 10 out of
25 lower income women (40%) reported not being
offered a choice between mastectomy and lumpectomy
with radiation. This is consistent with our lower SES
sample where 51% of participants reported not being
given a choice between surgical treatments for early-stage
breast cancer. Existing literature confirms that patients
of lower SES are more likely to play a passive role in
decision making.4,6,7,9,10 Consistent with previous studies
among lower SES patients, it is likely that differences in
SES between patients and health care professionals alter
communication patterns to potentially foster physician’s
control over decision making.8,11,53
Although many participants considered cost relevant
in deciding between surgical treatments, research indicates no overall long-term cost difference between mastectomy and lumpectomy.54 Lumpectomy seems to have
higher short-term costs but lower long-term costs than
mastectomy. Costs 1 year post surgery are also more
likely to be influenced by the use of adjuvant therapy
than by the type of surgery.54 Therefore, despite the
importance of cost in the overall decision-making process for 11 out of 39 patients, it does not clearly enable
interpretation of which option patients should logically
choose if they are particularly concerned about cost.
Consequently, cost was not included in the DQI-R.
Another study examined the quality of surgical decisions in Latina breast cancer patients and suggested that
some adaptations may be needed to increase acceptability
in the Latina population.35 That study concluded that the
different aspects of decision quality did not vary by level
of acculturation.35 As our study sample included a diverse
racial/ethnic makeup and varying levels of education and
income, this adapted version of DQI may be beneficial in
assessing the decision quality in women across socioeconomic strata and cultural backgrounds. It is worth noting
that the DQI is used across clinical domains for a wide
variety of decisions and with diverse populations.55–58
This work is relevant in the context of other versions of
the DQI. Aspects of the questionnaire that were challenging for early-stage breast cancer patients may be relevant
to patients diagnosed with other cancer types or medical
conditions (e.g., addition of a glossary).

Conclusions
Although the DQI was found to be broadly acceptable
and usable, our findings suggest that women of lower
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SES may have different goals and concerns compared
with the higher SES samples with whom this measure
had been previously developed and evaluated. Avoiding
additional surgery may be related to financial considerations, a concern that did not seem prominent in women
of higher SES who contributed to the development and
validation of the DQI. The addition of a glossary to facilitate understanding of key clinical terms is an important
contribution to improving the usability of the measure.
The proposed revisions to the DQI will be evaluated in a
large randomized controlled trial with a diverse patient
population to determine their performance. If the results
show strong reliability and validity in this population,
this revised version of the DQI will have broad applicability and could be used across SES groups, following a
proportionate universalism approach.59
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